SUBSCRIBE
SUBSCRIBE
News   Policy

Skyepharma PLC in Process of Filing Flutiform in EU

March 25, 2010 | 
1 min read

LONDON, March 25 (Reuters) - British drug delivery specialist SkyePharma (SKP.L) said it was in the process of filing its Flutiform asthma drug for European approval, following recent setbacks in the United States.

Regulatory Europe
MORE ON THIS TOPIC
Robert F Kennedy Jr speaking at the White House
Government
Calls To End Kennedy’s Leadership Follow Marks’ Abrupt Exit
April 1, 2025
 · 
2 min read
 · 
Tristan Manalac
FDA
Marks’ Sudden Departure From FDA Magnifies Uncertainty, Sends Biopharma Shares Down
March 31, 2025
 · 
3 min read
 · 
Heather McKenzie
A scientist with pill bottles in front of FDA headquarters
Regulatory
FDA Action Alert: Amgen, Aldeyra and Argenx
March 31, 2025
 · 
3 min read
 · 
Tristan Manalac
Wooden blocks with arrow and error icon. Delays and disruptions, stop the process, critical error concept
Alzheimer’s disease
EU Rejects Lilly’s Alzheimer’s Drug Kisunla, Following Same Path as Rival Leqembi
March 28, 2025
 · 
2 min read
 · 
Dan Samorodnitsky